Postmenopausal women with osteoporosis who reached their bone mineral density target on standard denosumab (Prolia, Xgeva) therapy maintained the benefit when they switched to a half-dose regimen.
First Look
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
